ALLMedicine™ Pulmonary Embolism Center

Dec 3rd, 2021 - EINSTEIN PE study demonstrated that rivaroxaban is at least as effective as the current standard therapy with 51% relative risk reduction of major bleeding (1.1% vs. 2.2%, HR 0.49, 95% CI, 0.31-0.79), in the treatment and secondary prevention of P...

Dec 3rd, 2021 - Closer reading of computed tomography pulmonary angiography (CTPA) scans of patients presenting with acute pulmonary embolism (PE) may identify those at high risk of developing chronic thromboembolic pulmonary hypertension (CTEPH). We aimed to val...

Dec 3rd, 2021 - Acute pulmonary embolism (PE) is one of the leading causes of maternal mortality, and cesarean section is an established independent risk factor for PE. The diagnostic utility of D-dimer for PE in non-pregnant women has been well-established, but ...

Dec 2nd, 2021 - During the COVID-19 pandemic, several studies described an increased chance of developing pulmonary embolism (PE). Several scores have been used to predict the occurrence of PE. In this systematic review, we aim at summarizing the literature on pr...

Dec 1st, 2021 - Postoperative venous thromboembolism (VTE) is a major and potentially fatal postoperative complication of colorectal cancer surgery. However, there is uncertainty about the necessity for anticoagulant prophylaxis to prevent VTE after laparoscopic ...

Apr 27th, 2021 - The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the appropriate use of point-of-care ultrasonography (POCUS) in patients with acute dyspnea in emergency department (ED) or inpatient settings...

Nov 25th, 2020 - Patients with cancer are at higher risk of more severe COVID-19 infection and have more associated complications. The position paper describes the management of cancer patients, especially those receiving anticancer treatment, during the COVID-19 ...

Oct 3rd, 2020 - Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), occurs in ∼1 to 2 individuals per 1000 each year, corresponding to ∼300 000 to 600 000 events in the United States annually. These evidence-based ...

Aug 12th, 2020 - Management of Acute Pulmonary Embolism.|2020|Paul JD,Cifu AS,|administration & dosage,administration & dosage,standards,diagnosis,mortality,therapy,standards,standards,standards,adverse effects,methods,mortality,standards,complications,therapy,

May 7th, 2020 - Iliofemoral venous thrombosis carries a high risk for pulmonary embolism, recurrent deep vein thrombosis, and post-thrombotic syndrome complicating 30% to 71% of those affected. The clinical scenarios in which iliofemoral venous thrombosis is mana...

Dec 3rd, 2021 - EINSTEIN PE study demonstrated that rivaroxaban is at least as effective as the current standard therapy with 51% relative risk reduction of major bleeding (1.1% vs. 2.2%, HR 0.49, 95% CI, 0.31-0.79), in the treatment and secondary prevention of P...

Nov 22nd, 2021 - In patients with intermediate-risk pulmonary embolism, full-dose thrombolytic treatment was associated with a reduction in the combined risk of hemodynamic instability or death but was also associated with an increased risk of major and intracrani...

Nov 19th, 2021 - The objective of the study is to evaluate the safety and efficacy of the Adient absorbable filter for the prevention of pulmonary embolism (PE: blood clot in the lungs). PE claims the lives of over 100,000 Americans each year, more than breast can...

Nov 18th, 2021 - In the current SARS-COV-2 pandemic there is a concern about an increased risk of venous thromboembolism (VTE) concurrent with the infection, including both pulmonary embolism (PE) and deep venous thrombosis (DVT) (Klok et al. 2020; Cui et al. 2020...

Nov 12th, 2021 - The pulmonary complications are the major cause of morbidity and mortality following Lung surgeries. The Buteyko breathing technique is used for reversing the health condition such as poor breathing, mouth breathing and over breathing. Incentive s...

Nov 22nd, 2021 - The addition of nivolumab (Opdivo) to chemotherapy resulted in a statistically significant and clinically meaningful improvement in event-free survival (EFS) vs chemotherapy alone, when administered prior to surgery in patients with resectable sta...

Nov 2nd, 2021 - Patients with rheumatoid arthritis who are treated with methotrexate (MTX) are more than twice as likely to develop venous thromboembolism (VTE) when compared with patients who use hydroxychloroquine, according to data from a propensity score–matc.

Oct 18th, 2021 - Editor's note, 18 October 2021: This article was updated to correct the title 'occupational therapists'. Watch for the big three red flags – cardiac (ischaemia, tachyarrhythmia, myocarditis and pericarditis), neurological (TIA and stroke) and resp...

Oct 13th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The plasma D-dimer assay has been used, along with clinical prediction scores, to rule out pulmonary embolism (PE) in critically ill patients for ...

Oct 7th, 2021 - Farrukh Awan, MD: We’ll keep talking about specific things. I’ll tell you a few specific issues that I deal with. I’m sure a lot of people in the audience might have to deal with these issues. I’ve had problems, and I’ve had discussions, arguments...